HOLX vs. DGX: Which Women's Health-Focused Stock Is the Better Pick?Zacks Investment Research • 05/27/25
Hologic to Present New Data at ASCO 2025 Reinforcing the Practice-Changing Role of the Breast Cancer Index® Test in Helping to Deliver More Personalized Care to PatientsBusiness Wire • 05/22/25
Tariffs Dim Hologic's 2025 Expectations: Time to Reassess the Stock?Zacks Investment Research • 05/12/25
Hologic Q2 Earnings & Revenues Top, '25 EPS View Lowered, Stock DownZacks Investment Research • 05/02/25
Medical equipment maker Hologic lowers annual profit forecast on tariff uncertaintyReuters • 05/01/25
Hologic (HOLX) Q2 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 05/01/25
Insights Into Hologic (HOLX) Q2: Wall Street Projections for Key MetricsZacks Investment Research • 04/28/25
Cellulite Treatment Market Trends, Growth Opportunities and Shares 2025-2030; Featuring Key Players - Hologic (Cynosure), Merz Pharma, Syneron Medical, Zimmer Aesthetics & MoreGlobeNewsWire • 04/25/25
Groundbreaking New Data on Hologic's AI-Powered Mammography Technology to Be Presented at SBIBusiness Wire • 04/24/25
Hologic vs. MYGN: Which Molecular Diagnostics Player Has More Upside?Zacks Investment Research • 04/22/25
Hologic Details Environmental, Social and Governance Efforts — Including Expanded Environmental Ambitions — in New Sustainability ReportBusiness Wire • 04/22/25
Hologic (HOLX) Advances While Market Declines: Some Information for InvestorsZacks Investment Research • 04/07/25
Hologic Brings in New Leadership: A Signal to Stay Put With the Stock?Zacks Investment Research • 04/07/25
Hologic to Announce Financial Results for the Second Quarter of Fiscal 2025 on Thursday, May 1, 2025Business Wire • 04/03/25